Co-Aggregation Of Amyloidogenic Proteins In Age-Related Neurodegenerative Diseases

Age-related neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, are increasingly understood as complex conditions where multiple amyloidogenic proteins interact and influence each other’s aggregation and toxicity, rather than acting independently.

For a long time, we thought of diseases like Alzheimer’s and Parkinson’s as being caused by a single problematic protein. However, new research suggests a more complex picture: these age-related brain disorders are actually driven by several “amyloidogenic” proteins working together. These proteins, including well-known culprits like Tau, alpha-synuclein, amyloid-beta, and TDP-43, don’t just clump up in isolation. Instead, they can “cross-seed” each other, meaning one type of protein clump can encourage others to form. They also tend to gather in the same brain regions and amplify each other’s harmful effects on brain cells. This new perspective proposes that neurodegeneration is a network of interacting misfolded proteins, influenced by various changes that occur as we age, such as alterations in cell membranes, chemical balance within cells, and the body’s ability to manage proteins. This shift in understanding is crucial because it opens up new avenues for developing better diagnostic tools, such as identifying specific markers in bodily fluids, and for creating more effective treatments that target these interconnected protein pathways, moving beyond the traditional “one protein, one disease” approach.

---

Source: link to paper